Drug
Cefprozil
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Sputum Discoloured | 21 | 59.9 | 61.5 | signal |
| 2 | Clostridium Difficile Colitis | 17 | 43.1 | 44.0 | signal |
| 3 | Secretion Discharge | 15 | 32.7 | 33.3 | signal |
| 4 | Chronic Kidney Disease | 89 | 31.2 | 35.1 | signal |
| 5 | Choking | 21 | 29.1 | 29.9 | signal |
| 6 | End Stage Renal Disease | 19 | 27.8 | 28.4 | signal |
| 7 | Ear Infection | 25 | 25.3 | 26.1 | signal |
| 8 | Dry Throat | 9 | 23.8 | 24.1 | signal |
| 9 | Ligament Sprain | 8 | 21.8 | 22.0 | signal |
| 10 | Pharyngitis | 9 | 19.4 | 19.6 | signal |
| 11 | Tubulointerstitial Nephritis | 13 | 18.7 | 19.0 | signal |
| 12 | Breast Pain | 7 | 17.7 | 17.8 | signal |
| 13 | Diarrhoea Haemorrhagic | 6 | 17.2 | 17.4 | signal |
| 14 | Renal Tubular Necrosis | 6 | 16.4 | 16.5 | signal |
| 15 | Colitis | 22 | 15.7 | 16.1 | signal |
| 16 | Sneezing | 13 | 15.6 | 15.9 | signal |
| 17 | Wheezing | 33 | 15.0 | 15.6 | signal |
| 18 | Obstructive Airways Disorder | 6 | 14.5 | 14.6 | signal |
| 19 | Splenomegaly | 6 | 13.8 | 13.9 | signal |
| 20 | Product Availability Issue | 11 | 13.2 | 13.4 | signal |
| 21 | Product Administration Error | 9 | 12.1 | 12.3 | signal |
| 22 | Sinus Congestion | 6 | 11.9 | 12.0 | signal |
| 23 | Blood Lactate Dehydrogenase Increased | 7 | 11.8 | 11.9 | signal |
| 24 | Oropharyngeal Pain | 39 | 11.3 | 11.9 | signal |
| 25 | Injection Site Extravasation | 5 | 10.8 | 10.8 | signal |
| 26 | Renal Injury | 12 | 10.7 | 10.9 | signal |
| 27 | Ear Discomfort | 4 | 10.5 | 10.6 | signal |
| 28 | Rotator Cuff Syndrome | 5 | 10.4 | 10.5 | signal |
| 29 | Lymphoma | 6 | 10.4 | 10.5 | signal |
| 30 | Pharyngitis Streptococcal | 4 | 9.9 | 10.0 | signal |
| 31 | Aphonia | 5 | 9.6 | 9.7 | signal |
| 32 | Neuroleptic Malignant Syndrome | 4 | 9.0 | 9.1 | signal |
| 33 | Drug Resistance | 7 | 7.3 | 7.4 | signal |
| 34 | Myocarditis | 3 | 7.1 | 7.1 | signal |
| 35 | Premature Delivery | 4 | 6.7 | 6.8 | signal |
| 36 | Tardive Dyskinesia | 6 | 5.7 | 5.7 | signal |
| 37 | Exposure Via Skin Contact | 4 | 4.8 | 4.8 | signal |
| 38 | Extrapyramidal Disorder | 3 | 3.2 | 3.2 | no signal |
| 39 | Wrong Technique In Device Usage Process | 3 | 1.8 | 1.8 | no signal |